...
首页> 外文期刊>Perspectives on science >Gene Patents: Perspective from the Clinic and the Laboratory
【24h】

Gene Patents: Perspective from the Clinic and the Laboratory

机译:基因专利:从临床和实验室的角度

获取原文
获取原文并翻译 | 示例
           

摘要

How could something you consider personal and essential to your unique identity, such as your genetic make-up, become commodified? There are precedents for treating blood and tissue samples containing genetic information as commodities. When researchers, institutions and companies consider samples to be commodities, they do not seek to determine the wishes of the patients and their families with regard to sample use, because they may seek to profit from the genetic material in the samples by obtaining patents on the genes. Patient advocacy groups and some governments have challenged gene patents, and have even sought controlling interests in them. Patient advocacy groups and professional organizations supported an attempt to overturn gene patents in the case, Association of Molecular Pathology, et al. v. U.S. Patent and Trademark Office, et al. (American Civil Liberties Union 2011). When the Supreme Court handed down its ruling on June 13, 20131 (Supreme Court of the United States 2013), it struck down patents on DNA isolated from nature, but not the patent for cDN A, DNA composed only of exons without introns.
机译:您认为个人化和独特身份必不可少的东西(例如您的基因组成)如何变得商品化?在处理包含遗传信息作为商品的血液和组织样本方面有先例。当研究人员,机构和公司将样品视为商品时,他们不会试图确定患者及其家属在样品使用方面的意愿,因为他们可能会通过从样品的遗传材料中获取专利来寻求收益。基因。患者倡导团体和一些政府对基因专利提出了挑战,甚至在其中寻求控股权。患者辩护团体和专业组织支持试图推翻基因专利的尝试,该案例涉及分子病理学协会等。诉美国专利商标局等。 (美国公民自由联盟,2011年)。最高法院于20131年6月13日作出裁决(美国最高法院,2013年)时,撤销了与自然界分离的DNA的专利,但未涉及cDN A的专利,后者仅由外显子组成,而无内含子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号